DNA vaccines coding for live viruses could soon be tested in people



DNA vaccines would be much easier to store than mRNA alternatives and should be as effective as conventional vaccines that contain live viruses

By Michael Le Page

A US company has filed for approval to test DNA vaccines in people

David Talukdar/Shutterstock

The first human trials of DNA vaccines designed to produce live viruses in people’s bodies could start next year. A US company called Medigen has told New Scientist it is seeking approval for such trials.

The aim is to combine the potential advantages of DNA vaccines, including rapid manufacturing and easy storage, with the greater efficacy of vaccines that consist of live weakened viruses.

“So instead of giving live virus, we would give a piece of DNA and …

View introductory offers

No commitment, cancel anytime*

Offer ends 28th October 2023.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)


Existing subscribers

Sign in to your account

More from New Scientist

Explore the latest news, articles and features


Please enter your comment!
Please enter your name here

Share post:




More like this

Don’t Allow Yourself To Be Used

  Nigerian man, Darosha Losobeh, who is the cousin and...

‘It’s a Wonderful Life’ quiz! How well do you know this iconic film?

Watching cherished holiday movies is one of the best...

‘Saved by the Bell’ star Tiffani Thiessen ‘fell in love’ with ice plunging as she nears 50

Tiffani Thiessen is welcoming change. The actress will celebrate...